Group 1: Regulatory Developments - The National Medical Products Administration (NMPA) is seeking public opinion on measures to optimize lifecycle regulation supporting high-end medical device innovation [1] - The draft emphasizes strengthening standards to lead innovation and improving the high-end medical device standard system [1] - Accelerated publication of standards for medical exoskeleton robots and radioactive nuclide imaging devices is planned [1] Group 2: Industry Trends - AI in healthcare is highlighted as a significant innovation direction, enhancing medical device functionality and clinical decision-making [1] - Companies are expected to leverage AI to improve product competitiveness and customer loyalty, solidifying their market position [1] Group 3: Company Performance - MicroPort Robotics (02252) is experiencing strong order trends, with sales contribution from robotics expected to rise from approximately 3% in 2024 to about 40% by 2033 [2] - Yimaitong (02522) is advancing in medical imaging services and has launched an AI company that released a global first full-modal medical imaging model [2] - Yongsheng Medical (01612) reported a revenue of approximately HKD 801 million for 2024, a year-on-year increase of 11.6%, driven by increased orders in imaging disposable products [3] - Kangji Medical (09997) is set to launch its surgical robot business, with significant investments in its subsidiary Weijing Medical, which has completed clinical trials for its four-arm surgical robot system [4]